DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Cantor Fitzgerald Maintains Overweight on Aurinia Pharmaceuticals, Raises Price Target to $32

Cantor Fitzgerald analyst Alethia Young maintains Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Overweight and raises the price target from $30 to $32.

Benzinga · 03/06/2020 11:30

Cantor Fitzgerald analyst Alethia Young maintains Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Overweight and raises the price target from $30 to $32.